astragaloside a has been researched along with Acute Kidney Injury in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Tang, JL; Xin, M; Zhang, LC | 1 |
Chen, D; Feng, M; Guo, H; Lv, J; Su, L; Tu, Y; Wang, Z; Zhang, C | 1 |
Gao, H; Gong, J; Hu, T; Li, Z; Qu, X; Song, Y; Sun, J; Tao, L; Zhai, J; Zhang, Y | 1 |
Chen, Y; Zhang, X; Zhou, W | 1 |
Chai, XQ; He, KQ; Jiang, Y; Li, WP; Li, WZ; Yin, YY | 1 |
Gui, D; Guo, Y; Huang, J; Liu, W; Wang, N; Xiao, W | 1 |
6 other study(ies) available for astragaloside a and Acute Kidney Injury
Article | Year |
---|---|
Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
Topics: Acute Kidney Injury; Astragalus propinquus; Humans; Lipopolysaccharides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Sepsis; Triterpenes | 2022 |
Astragaloside IV Protects Sepsis-induced Acute Kidney Injury by Attenuating Mitochondrial Dysfunction and Apoptosis in Renal Tubular Epithelial Cells.
Topics: Acute Kidney Injury; Animals; Apoptosis; Electron Transport Complex I; Epithelial Cells; Mice; Mitochondria; Saponins; Sepsis | 2022 |
Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Biomarkers; Chromatography, High Pressure Liquid; Cisplatin; Male; Mass Spectrometry; Metabolome; Metabolomics; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2021 |
Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.
Topics: Acute Kidney Injury; Animals; Cytokines; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Interleukin-6; Kidney; Lipopolysaccharides; Male; Mice; Models, Animal; Reactive Oxygen Species; Receptors, CCR5; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2017 |
Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
Topics: Acute Kidney Injury; Animals; Antioxidants; Collagen Type IV; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Humans; Hyperinsulinism; Iatrogenic Disease; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2018 |
Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Apoptosis; Caspase 3; Cell Adhesion Molecules; Cystatin C; Drugs, Chinese Herbal; Ischemia; Kidney; Kidney Function Tests; Lipocalin-2; Lipocalins; Male; Models, Animal; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Renal Artery; Reperfusion Injury; RNA, Messenger; Saponins; Triterpenes | 2013 |